SEEM |
Q3 Financial Statements at January 31, 2024 |
Interim Financial Statements |
28/03/2024 |
Open Filing (484.48 KB) |
POLE |
Form 7 February 2024 |
Monthly Progress Report |
28/03/2024 |
Open Filing (142.66 KB) |
POLE |
Form 7 January |
Monthly Progress Report |
28/03/2024 |
Open Filing (142.64 KB) |
BDR |
Jan.31, 2024 CFO Certificate |
Certificate of compliance |
28/03/2024 |
Open Filing (100.97 KB) |
BDR |
Jan.31, 2024 CEO Certificate |
Certificate of compliance |
28/03/2024 |
Open Filing (101.02 KB) |
BDR |
Jan. 31, 2024 MD&A |
MD&A (Management Discussion and Analysis) |
28/03/2024 |
Open Filing (188.83 KB) |
BDR |
Jan 31, 2024 Financial Statements |
Interim Financial Statements |
28/03/2024 |
Open Filing (194.74 KB) |
RAMM |
RAMM Pharma Corp. Announces Corporate Update |
Press Release |
28/03/2024 |
Open Filing (223.73 KB) |
MUSK |
Notice of Proposed New RSU Grant |
Proposed Stock Option |
28/03/2024 |
Open Filing (149.63 KB) |
NLR |
Certificate - CEO |
Certificate of compliance |
28/03/2024 |
Open Filing (193.48 KB) |